Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
The answer was that it remains to be seen during phase 3
This means it may bring common side effects or uncommon health hazards
Collectively, the strong neuroanatomical enrichment of PDE1B and PDE10A within schizophrenia-relevant neuronal circuits, coupled with supportive preclinical evidence for PDE1B and more advanced clinical pharmacology for PDE10A, provides a compelling rationale to prioritize these isoforms over PDE2, PDE4, PDE8, and PDE9 in schizophrenia drug development
Clinical Trials and Promising Results Multiple clinical trials are underway, with early clinical trials producing exciting data
Continue for 16 to 24 weeks minimum before assessing results
.jpg)